Published: March 3, 2026 . The English Chronicle Desk . The English Chronicle Online
Lymphoedema — a condition marked by chronic swelling and discomfort — remains a largely under‑recognised consequence of cancer and cancer treatment, even as more survivors live longer after diagnosis. The condition can develop when the body’s lymphatic system — a critical part of the immune and fluid‑transport system — is damaged by cancer itself, surgery or radiotherapy, leading to a persistent buildup of lymph fluid in tissues beneath the skin. Despite affecting a significant proportion of patients, lymphoedema’s impact on physical health, mobility and quality of life is often overlooked in post‑treatment care and public discourse.
The lymphatic system includes an extensive network of vessels and nodes that drain excess fluid from tissues and help the immune system function. When cancer invades lymph nodes, or when these nodes are removed or scarred by radiation, the system cannot efficiently transport lymph fluid. The result is swelling in affected areas, most commonly arms or legs but sometimes the head, neck or torso depending on the site of treatment. For example, one in five women treated for breast cancer will develop lymphoedema, and the condition occurs in a substantial proportion of patients treated for pelvic, genital or head and neck cancers.
Unlike short‑term post‑surgical swelling, lymphoedema is typically chronic. It may appear months or even years after cancer therapy, complicating detection and long‑term care. Survivors may initially notice a feeling of heaviness or fullness in an arm or leg, slight swelling of soft tissues, changes in skin texture, and reduced mobility. Over time, if untreated, the fluid build‑up can become more pronounced, leading to pain, recurrent infections like cellulitis and significant functional limitations.
One of the reasons lymphoedema remains “hidden” is that its symptoms can be subtle at first and are sometimes dismissed as normal post‑treatment effects. Patients and even some clinicians may be unaware of the risk, leading to delayed diagnosis and intervention. Early warning signs — such as tightness in the limb, small but persistent swelling, or changes in how clothing fits — should prompt clinical evaluation, because early intervention can slow progression and reduce long‑term disability.
Treatment focuses on symptom management rather than cure, with strategies designed to improve lymph flow and reduce swelling. These include manual lymphatic drainage (a specialised massage technique), compression garments, targeted exercises to encourage fluid circulation, meticulous skin care to prevent infection and, in some cases, surgical options to remove excess tissue or reconstruct lymphatic pathways. For many survivors, managing lymphoedema can become a daily regimen requiring time, specialised care and often significant financial resources — a burden that compounds the emotional and physical challenges of cancer survivorship.
Beyond its physical consequences, lymphoedema often carries psychological and social impacts. Persistent swelling can alter body image, reduce independence in daily activities and, in some cases, lead to depression or anxiety. Patients have described the condition as life‑altering, affecting work, exercise and even simple tasks like dressing or walking comfortably.
Medical professionals and advocacy groups are calling for greater awareness and structured follow‑up for at‑risk patients. Education about risk factors, routine monitoring for early signs, and timely referral to specialists can improve outcomes. Moreover, integrating lymphoedema care into survivorship plans acknowledges its status not as an inevitable complication but as a manageable condition when addressed proactively.
As cancer care advances and survivorship increases globally, lymphoedema stands out as a reminder that overcoming the primary disease is only part of the journey. Comprehensive support and recognition of conditions like lymphoedema are crucial to improving long‑term health and quality of life for millions of cancer survivors worldwide.


























































































